title: Is vitamin e or ursodeoxycholic acid a valid treatment option for nonalcoholic fatty liver disease in 2016?
authors.affiliation: Department of Medicine, Division of Gastroenterology, Western University, London, ON N6A 5A5, Canada.
authors.forename: Melanie D
authors.initials: MD
authors.lastname: Beaton
authors.affiliation: Department of Medicine, Division of Gastroenterology, Western University, London, ON N6A 5A5, Canada; Department of Medicine, King Saud University, Riyadh, Saudi Arabia.
authors.forename: Bandar
authors.initials: B
authors.lastname: Al-Judaibi
mesh_terms: D002756:Cholagogues and Choleretics / Q000627:therapeutic use; D005234:Fatty Liver / Q000188:drug therapy; D006801:Humans; D008099:Liver; D065626:Non-alcoholic Fatty Liver Disease / Q000188:drug therapy*; D014580:Ursodeoxycholic Acid / Q000627:therapeutic use*; D014810:Vitamin E / Q000627:therapeutic use
chemical_list: D002756:Cholagogues and Choleretics; D014810:Vitamin E; D014580:Ursodeoxycholic Acid